- Home
- CRMD vs BCSF Comparison
CRMD vs BCSF Comparison
Compare CRMD & BCSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRMD
- BCSF
- Stock Information
- Founded
- CRMD 2006
- BCSF 2015
- Country
- CRMD United States
- BCSF United States
- Employees
- CRMD N/A
- BCSF N/A
- Industry
- CRMD Biotechnology: Pharmaceutical Preparations
- BCSF Finance/Investors Services
- Sector
- CRMD Health Care
- BCSF Finance
- Exchange
- CRMD Nasdaq
- BCSF Nasdaq
- Market Cap
- CRMD 865.2M
- BCSF 983.4M
- IPO Year
- CRMD 2010
- BCSF 2018
- Fundamental
- Price
- CRMD $11.20
- BCSF $13.79
- Analyst Decision
- CRMD Strong Buy
- BCSF Buy
- Analyst Count
- CRMD 8
- BCSF 2
- Target Price
- CRMD $17.57
- BCSF $16.50
- AVG Volume (30 Days)
- CRMD 2.9M
- BCSF 406.7K
- Earning Date
- CRMD 10-29-2025
- BCSF 11-04-2025
- Dividend Yield
- CRMD N/A
- BCSF 12.88%
- EPS Growth
- CRMD N/A
- BCSF N/A
- EPS
- CRMD 0.79
- BCSF 1.66
- Revenue
- CRMD $121,484,498.00
- BCSF $283,687,000.00
- Revenue This Year
- CRMD $446.49
- BCSF N/A
- Revenue Next Year
- CRMD $59.96
- BCSF N/A
- P/E Ratio
- CRMD $14.61
- BCSF $8.41
- Revenue Growth
- CRMD 14970.29
- BCSF N/A
- 52 Week Low
- CRMD $5.60
- BCSF $13.20
- 52 Week High
- CRMD $17.43
- BCSF $19.21
- Technical
- Relative Strength Index (RSI)
- CRMD 41.16
- BCSF 28.41
- Support Level
- CRMD $10.95
- BCSF $13.93
- Resistance Level
- CRMD $11.71
- BCSF $14.37
- Average True Range (ATR)
- CRMD 0.53
- BCSF 0.29
- MACD
- CRMD 0.01
- BCSF -0.06
- Stochastic Oscillator
- CRMD 12.69
- BCSF 11.71
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
About BCSF Bain Capital Specialty Finance Inc.
Bain Capital Specialty Finance Inc is an externally managed, closed-end, non-diversified management investment company. The company's objective is to provide risk-adjusted returns and current income to investors by investing predominantly in middle-market companies with between $10.0 million and $150.0 million in annual EBITDA. Its portfolio of investments includes First Lien Senior Secured Loan, Preferred Equity, Equity Interest, Warrants, and Second Lien Senior Secured Loan among others.